JE
JMAC Enterprises Portfolio holdings
AUM
$467M
This Quarter Return
+9.09%
1 Year Return
+12.91%
3 Year Return
+54.99%
5 Year Return
–
10 Year Return
–
AUM
$364M
AUM Growth
+$364M
(+2.1%)
Cap. Flow
-$21.8M
Cap. Flow
% of AUM
-6%
Top 10 Holdings %
Top 10 Hldgs %
37.94%
Holding
180
New
8
Increased
28
Reduced
112
Closed
6
Top Buys
| 1 |
Blackrock
BLK
|
$259K |
| 2 |
Air Products & Chemicals
APD
|
$237K |
| 3 |
DuPont de Nemours
DD
|
$228K |
| 4 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$224K |
| 5 |
iShares US Healthcare ETF
IYH
|
$223K |
Top Sells
Sector Composition
| 1 | Healthcare | 10.67% |
| 2 | Technology | 4.79% |
| 3 | Consumer Staples | 3.26% |
| 4 | Financials | 2.07% |
| 5 | Consumer Discretionary | 2.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
151
Blackrock
BLK
$173B
| $259K | 0.07% |
+365
| New | +$259K |
|
152
Mondelez International
MDLZ
$80B
| $255K | 0.07% |
3,831
-3
| -0.1% | -$200 |
|
153
Intel
INTC
$106B
| $243K | 0.07% |
9,192
-800
| -8% | -$21.1K |
|
154
CMS Energy
CMS
$21.3B
| $240K | 0.07% |
3,792
| – | – |
|
155
Applied Materials
AMAT
$126B
| $240K | 0.07% |
2,461
-5
| -0.2% | -$487 |
|
156
Citigroup
C
$174B
| $236K | 0.06% |
5,211
-2,610
| -33% | -$118K |
|
157
Ferrari
RACE
$87.7B
| $235K | 0.06% |
1,097
-69
| -6% | -$14.8K |
|
|
158
DuPont de Nemours
DD
$31.7B
| $228K | 0.06% |
+3,323
| New | +$228K |
|
159
ASML
ASML
$285B
| $227K | 0.06% |
415
-194
| -32% | -$106K |
|
|
160
Vanguard FTSE Emerging Markets ETF
VWO
$96.2B
| $224K | 0.06% |
+5,745
| New | +$224K |
|
161
iShares Biotechnology ETF
IBB
$5.69B
| $224K | 0.06% |
1,703
-3
| -0.2% | -$394 |
|
162
TSMC
TSM
$1.18T
| $224K | 0.06% |
3,001
| – | – |
|
|
163
iShares US Healthcare ETF
IYH
$2.76B
| $223K | 0.06% |
+786
| New | +$223K |
|
164
Alcon
ALC
$38.7B
| $217K | 0.06% |
+3,163
| New | +$217K |
|
165
Hershey
HSY
$37.7B
| $216K | 0.06% |
931
| – | – |
|
166
NextEra Energy, Inc.
NEE
$150B
| $206K | 0.06% |
+2,470
| New | +$206K |
|
|
WBA
167
DELISTED
Walgreens Boots Alliance
WBA
| $205K | 0.06% |
5,500
-8,100
| -60% | -$303K |
|
168
Prologis
PLD
$103B
| $203K | 0.06% |
+1,803
| New | +$203K |
|
169
ResMed
RMD
$39.7B
| $202K | 0.06% |
971
| – | – |
|
170
Oracle
ORCL
$633B
| $200K | 0.06% |
+2,451
| New | +$200K |
|
171
Ford
F
$46.6B
| $187K | 0.05% |
16,118
+244
| +2% | +$2.84K |
|
172
Eledon Pharmaceuticals
ELDN
$153M
| $124K | 0.03% |
54,538
| – | – |
|
|
BCLI
173
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $66.3K | 0.02% |
40,430
| – | – |
|
174
Moleculin Biotech
MBRX
$11.4M
| $13.9K | ﹤0.01% |
13,132
| – | – |
|
175
Crown Castle
CCI
$42.7B
| – | – |
-2,500
| Closed | -$361K |
|